Pluri Inc. (PLUR) — 10-Q Filings

10-Q Filings (6)

• Pluri's Mounting Losses Raise Going Concern Doubts Amid Cash Burn — Nov 12, 2025 Risk: high
  Pluri Inc. reported a net loss of $6.132 million for the three months ended September 30, 2025, a slight increase from the $6.036 million net loss in the same p
• Pluri Inc. Files Q1 2025 10-Q Report — May 13, 2025 Risk: low
  Pluri Inc. filed its 10-Q report for the quarterly period ended March 31, 2025. The company, formerly known as Pluristem Therapeutics Inc., is incorporated in N
• Pluri Inc. Files 10-Q for Q4 2024 — Feb 11, 2025 Risk: medium
  Pluri Inc. filed its 10-Q report for the quarterly period ended December 31, 2024. The company, formerly known as Pluristem Therapeutics Inc., is incorporated i
• Pluri Inc. Files Q3 2024 10-Q Report — Nov 12, 2024 Risk: medium
  Pluri Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2024. The company, formerly known as Pluristem Therapeutics Inc., is incor
• Pluri Inc. Files 10-Q for Quarterly Period Ended March 31, 2024 — May 9, 2024 Risk: low
  Pluri Inc. (PLUR) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Pluri Inc. filed a 10-Q report for the quarterly period ended March 31, 2024. The
• Pluri Inc. Files 10-Q for Period Ended December 31, 2023 — Feb 12, 2024 Risk: low
  Pluri Inc. (PLUR) filed a Quarterly Report (10-Q) with the SEC on February 12, 2024. Pluri Inc. filed a 10-Q report for the quarterly period ended December 31,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX